Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

被引：4

作者：

Uutela, Aki ^{[1
,2
,3
]}

Nordin, Arno ^{[1
,2
]}

Osterlund, Emerik ^{[1
,2
,4
]}

Halonen, Paeivi ^{[2
,5
]}

Kallio, Raija ^{[6
]}

Soveri, Leena-Maija ^{[7
,8
]}

Salminen, Tapio ^{[9
,10
]}

Algars, Annika ^{[11
,12
]}

Ristimaki, Ari ^{[2
,13
]}

Ovissi, Ali ^{[2
,14
]}

Lamminmaki, Annamarja ^{[15
,16
]}

Muhonen, Timo ^{[8
,17
]}

Kononen, Juha ^{[18
,19
]}

Ristamaki, Raija ^{[11
,12
]}

Heerva, Eetu ^{[11
,12
]}

Stedt, Hanna ^{[15
,16
]}

Lehtomaki, Kaisa ^{[9
,10
]}

Kytola, Soili ^{[2
,20
]}

Sundstrom, Jari ^{[12
,21
]}

Makinen, Markus J. ^{[22
]}

Nieminen, Lasse ^{[10
]}

Kuopio, Teijo

Keinanen, Mauri

Osterlund, Pia ^{[2
,5
,9
,10
]}

Isoniemi, Helena ^{[1
,2
]}

机构：

[1] Helsinki Univ Hosp, Abdominal Ctr, Dept Transplantat & Liver Surg, Helsinki, Finland

[2] Univ Helsinki, Helsinki, Finland

[3] Royal Infirm Edinburgh NHS Trust, Dept Transplant & Hepatopancreatobiliary Surg, Edinburgh, Scotland

[4] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden

[5] Helsinki Univ Hosp, Dept Oncol, Comprehens Canc Ctr, Helsinki, Finland

[6] Oulu Univ Hosp, Dept Oncol, Oulu, Finland

[7] Joint Municipal Author Hlth Care & Social Serv Kes, Home Care Geriatr Clin & Palliat Care, Hyvinkaa, Uusimaa, Finland

[8] Univ Helsinki, Fac Med, Helsinki, Finland

[9] Tampere Univ Hosp, Dept Oncol, Tampere, Finland

[10] Univ Tampere, Tampere, Finland

[11] Turku Univ Hosp, Dept Oncol, Turku, Finland

[12] Univ Turku, Dept Pathol, Turku, Finland

[13] Helsinki Univ Hosp, HUS Diagnost Ctr & Appl Tumour Genom, Dept Pathol, Res Programmes Unit, Helsinki, Finland

[14] Helsinki Univ Hosp, HUS Med Imaging Ctr, Dept Radiol, Helsinki, Finland

[15] Kuopio Univ Hosp, Dept Oncol, Kuopio, Finland

[16] Univ Eastern Finland, Abdominal Ctr, Transplantat & Liver Surg, Haartmaninkatu 4,Bldg 1, Kuopio 00029, Finland

[17] South Carel Cent Hosp, Dept Oncol, Haartmaninkatu 4,Bldg 1, Lappeenranta 00029, Finland

[18] Cent Finland Hosp Nova, Dept Oncol, Jyvaskyla, Finland

[19] Docrates Canc Ctr, Helsinki, Finland

[20] Helsinki Univ Hosp, HUS Diagnost Ctr, Dept Genet, HUSLAB, Helsinki, Finland

[21] Turku Univ Hosp, Dept Pathol, Turku, Finland

[22] Oulu Univ Hosp, Dept Pathol, Oulu, Finland

来源：

BRITISH JOURNAL OF SURGERY | 2023年 / 110卷 / 08期

关键词：

POOLED ANALYSIS; CANCER; BEVACIZUMAB; FOLFOXIRI; KRAS;

D O I：

10.1093/bjs/znac424

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：931 / 935

页数：5

共 50 条

[21] Smoking and risk of colorectal cancer according to KRAS and BRAF mutation status in a Japanese prospective Study
Nakano, Shiori
Yamaji, Taiki
Shiraishi, Kouya
Hidaka, Akihisa
Shimazu, Taichi
Kuchiba, Aya
Saito, Masahiro
Kunishima, Fumihito
Nakaza, Ryouji
Kohno, Takashi
Sawada, Norie
Inoue, Manami
Tsugane, Shoichiro
Iwasaki, Motoki
CARCINOGENESIS, 2023, 44 (06) : 476 - 484
[22] Current status of laparoscopic liver resection for the management of colorectal liver metastases
Kabir, Tousif
Syn, Nicholas
Goh, Brian K. P.
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (03) : 526 - 539
[23] Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status
Yamashita, Suguru
Sheth, Rahul A.
Niekamp, Andrew S.
Aloia, Thomas A.
Chun, Yun Shin
Lee, Jeffrey E.
Vauthey, Jean-Nicolas
Conrad, Claudius
ANNALS OF SURGERY, 2017, 266 (06) : 1045 - 1054
[24] Can the mutational status of KRAS drive the treatment of colorectal liver metastases?
Muttillo, Edoardo M.
Felli, Emanuele
HPB, 2021, 23 (04) : 643 - 643
[25] A prospective study of oxaliplatin and capecitabine (CapOx) in metastatic colorectal cancer (MCRC) with baseline stratification according to resectability status
Watkins, D. J.
Jackson, C.
Chua, Y.
Chong, G.
Norman, A. R.
Brown, G.
Mudan, S.
Karanjia, N.
Cunningham, D.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[26] Importance of the Resection Status in the Surgery for Patients with colorectal Liver Metastases
Manekeller, Steffen
ZENTRALBLATT FUR CHIRURGIE, 2021, 146 (04):
[27] Prognostic Impact of KRAS Mutational Status in Patients with Colorectal Cancer Liver Metastases Differs According to the Location of the Primary Tumor
Amini, Neda
Margonis, Georgios Antonios
Kreis, Martin E.
Poultsides, George A.
Sasaki, Kazunari
Wagner, Doris
Pikoulis, Emmanouil
Weiss, Matthew J.
Wolfgang, Christopher L.
Safar, Bashar
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S69 - S70
[28] BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases
Kobayashi, Shin
Takahashi, Shinichiro
Nomura, Shogo
Kojima, Motohiro
Kudo, Masashi
Sugimoto, Motokazu
Konishi, Masaru
Gotohda, Naoto
Taniguchi, Hiroya
Yoshino, Takayuki
CANCER MEDICINE, 2021, 10 (20): : 6998 - 7011
[29] ANATOMIC RESECTION OF COLORECTAL LIVER METASTASES DOES NOT IMPROVE OUTCOMES OVER NON-ANATOMIC RESECTION REGARDLESS OF RAS MUTATION STATUS
Vreeland, Timothy J.
Joechle, Katharina
Okuno, Masayuki
Vega, Eduardo A.
Newhook, Timothy E.
Chun, Yun Shin
Aloia, Thomas
Tzeng, Ching-Wei
Lee, Jeffrey E.
Vauthey, Jean-Nicolas
GASTROENTEROLOGY, 2019, 156 (06) : S1395 - S1395
[30] Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13
Kawamata, Hiroshi
Yamashita, Keishi
Kojo, Ken
Ushiku, Hideki
Ooki, Akira
Watanabe, Masahiko
GENOMICS, 2015, 106 (02) : 71 - 75

← 1 2 3 4 5 →